Functional analysis of Sendai virus C protein

仙台病毒C蛋白的功能分析

基本信息

  • 批准号:
    12670292
  • 负责人:
  • 金额:
    $ 2.24万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2000
  • 资助国家:
    日本
  • 起止时间:
    2000 至 2001
  • 项目状态:
    已结题

项目摘要

(1) Mapping of the functional sites on the C protein.1) C(del10-15) mutan t: Preparing a mutant with a deletion at the position 10-15 of the C protein, we showed that amino acids at 10-15 were indispensable for inhibition of STAT1 stabilization, resistance against the anti-viral state of the host cells, suppression of apoptosis and expression of pathogenicity. These amino acids, however, were not involved in phosphorylation of STAT1, inhibition of the trans activation of ISGs as well as suppression of viral RNA polymerase activity.2) C170Ser(MVC11) mutant : A single point mutation at C170Phe→Ser demonstrated that C170 plays an important role in suppression of viral RNA polymerase activity, inhibition of STAT 1 stability and phosphorylation, inhibition of transact!vation of ISGs, suppression of apoptosis, resistance against anti-viral state of the host cells and expression of viral virulence. The Phe, however, had no relation with the formation of virus particles.(2) Mechanism ofattenua … More tion of the C protein mutant.1) Interferon sensitivity : When MVC11 was infected to interferon α/β receptor (IFNR)-knock-out mice (A129), mice exhibited only slight decrease of body weight. The result demonstrated that MVC11 was attenuated in A129 to the same degree as in ordinary mice possessing IFNR, suggesting that interferon sensitivity alone does not explain the attenuation of MVC11.2) Effect of death of infected cells : MVC11, an attenuated virus with a mutation in the C protein, induced necrosis as well as apoptosis. Death of the infected cells caused interruption of progeny virus production afterwards, and resulted in attenuation of viral pathogenicity. On the other hand, parental pathogenic virus Ml did not demonstrate significant cytopathic effect and released progeny virus continuously for a long time after infection. In the presence of caspase inhibitors which suppressed apoptosis but not necrosis, MVC11-infected cells died rapidly. These results suggested that necrosis plays an important role in causing death to attenuated virus-infected cells.(3) Mechanism ofapoptosis-induction by MVC11.Using the specific inhibitors of each caspase, we demonstrated that activation of caspase 8 occurred during apoptosis induced by MVC11. On the other hand, it was shown that caspase 9 had less relation to MVC11-induced apoptosis. FADD molecule was not involved in the activation of caspase 8.(4) Localization of C170Ser.C170Ser, when expressed independently from other MVC11 proteins, strongly interacted with cytoskeleton. The phenomenon might have some relation with induction of apoptosis by C170Ser. Less
(1)C蛋白上功能位点的定位。1)C(del 10 -15)突变体t:制备在C蛋白的位置10-15处具有缺失的突变体,我们表明10-15处的氨基酸对于抑制STAT 1稳定、抵抗宿主细胞的抗病毒状态、抑制细胞凋亡和表达致病性是必不可少的。2)C170 Ser(MVC 11)突变体:C170 Phe →Ser的单点突变表明,C170在抑制病毒RNA聚合酶活性、抑制STAT 1稳定性和磷酸化、抑制ISGs的反式激活以及抑制病毒RNA聚合酶活性等方面发挥重要作用。ISG的表达、细胞凋亡的抑制、对宿主细胞的抗病毒状态的抗性和病毒毒力的表达。而苯丙氨酸则与病毒粒子的形成无关。(2)衰减机理 ...更多信息 干扰素敏感性:当MVC 11感染干扰素α/β受体(IFNR)敲除小鼠(A129)时,小鼠体重仅轻微下降。结果表明,MVC 11在A129中的减毒程度与在具有IFNR的普通小鼠中的减毒程度相同,这表明干扰素敏感性单独不能解释MVC 11的减毒。2)感染细胞死亡的影响:MVC 11是一种在C蛋白中具有突变的减毒病毒,诱导坏死以及凋亡。感染细胞的死亡导致子代病毒生产中断,导致病毒致病性减弱。另一方面,亲本致病性病毒Ml没有表现出显著的细胞病变效应,并且在感染后长时间持续释放子代病毒。在存在抑制凋亡但不抑制坏死的半胱天冬酶抑制剂的情况下,MVC 11感染的细胞迅速死亡。这些结果表明,坏死在致弱病毒感染细胞死亡中起重要作用。(3)MVC 11诱导细胞凋亡的机制。利用caspase 8的特异性抑制剂,我们证实了在MVC 11诱导细胞凋亡的过程中,caspase 8被激活。另一方面,显示caspase 9与MVC 11诱导的细胞凋亡关系较小。FADD分子不参与caspase 8的激活。(4)C170 Ser的定位,C170 Ser,独立于其他MVC 11蛋白表达时,强烈的细胞骨架相互作用。这可能与C170 Ser诱导细胞凋亡有关。少

项目成果

期刊论文数量(21)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Nakagawa, Naoko et al.: "Antigenic variants with amino acid deletions clarify a neutralizing epitope specific for influenza B virus Victoria group strains"Journal of Virology. 82(9). 2169-2172 (2001)
Nakakawa、Naoko 等人:“氨基酸缺失的抗原变体阐明了 B 型流感病毒维多利亚组毒株特异的中和表位”《病毒学杂志》。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Yoshida, Isao et al.: "Inhibition of p21/Waf1/Cip1/Sdi1 expression by hepatitis C virus core protein"Microbiology and Immunology. 45(10). 689-697 (2001)
Yoshida, Isao 等人:“丙型肝炎病毒核心蛋白对 p21/Waf1/Cip1/Sdi1 表达的抑制”微生物学和免疫学。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Lusida, Maria Inge et al.: "Correlation between mutations in the interferon sensitivity-determining region of NS5A protein and viral load of hepatitis C virus subtypes 1b. 1c and 2a"Journal of Clinical Microbiology. 39(11). 3858-3864 (2001)
Lusida、Maria Inge 等人:“NS5A 蛋白干扰素敏感性决定区突变与丙型肝炎病毒亚型 1b、1c 和 2a 病毒载量之间的相关性”《临床微生物学杂志》。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Yoshida, Isao et al.: "Inhibition of p2l/Waf1/Cip1/Sdi1 expression by hepatitis C virus core protein"Microbiology and Immunology. 45(10). 689-697 (2001)
Yoshida, Isao 等人:“丙型肝炎病毒核心蛋白对 p2l/Waf1/Cip1/Sdi1 表达的抑制”微生物学和免疫学。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Nakagawa,Naoko: "Characterization of new epidemic strains of influenza B virus by using neutralizing monoclonal antibodies."Journal of Medical Virology. (in press). (2001)
中川直子:“使用中和单克隆抗体表征乙型流感病毒新流行株。”医学病毒学杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ITOH Masae其他文献

ITOH Masae的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ITOH Masae', 18)}}的其他基金

Study on the molecular mechanism of neuropathogenicity of a subacute sclerosing panencephalitis (SSPE) virus
亚急性硬化性全脑炎(SSPE)病毒神经致病性分子机制研究
  • 批准号:
    19K08941
  • 财政年份:
    2019
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular model of accumulation of multiple mutations on the way of transition of a measles virus to a subacute sclerosing panencephalitis virus
麻疹病毒向亚急性硬化性全脑炎病毒转变过程中多个突变积累的分子模型
  • 批准号:
    24591589
  • 财政年份:
    2012
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Genetic analysis of measles viruses isolated in Japan and mechanism of transmission-role of antibodies induced by vaccination
日本分离的麻疹病毒基因分析及传播机制——疫苗接种诱导抗体的作用
  • 批准号:
    15390211
  • 财政年份:
    2003
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of multily attenuated Sendai virus vaccine by means of reverse genetics
利用反向遗传学开发多重减毒仙台病毒疫苗
  • 批准号:
    10680785
  • 财政年份:
    1998
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

CORE C- Protein Expression and Purification
CORE C-蛋白表达和纯化
  • 批准号:
    10471911
  • 财政年份:
    2021
  • 资助金额:
    $ 2.24万
  • 项目类别:
CORE C- Protein Expression and Purification
CORE C-蛋白表达和纯化
  • 批准号:
    10661626
  • 财政年份:
    2021
  • 资助金额:
    $ 2.24万
  • 项目类别:
CORE C- Protein Expression and Purification
CORE C-蛋白表达和纯化
  • 批准号:
    10268696
  • 财政年份:
    2021
  • 资助金额:
    $ 2.24万
  • 项目类别:
Structural basis of innate immune evasion by Paramyxovirus C protein involving the binding to the novel counterpart
副粘病毒 C 蛋白逃避先天免疫的结构基础,涉及与新型对应物的结合
  • 批准号:
    20K06507
  • 财政年份:
    2020
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Measles virus C protein: polymerase interactions and innate immunity evasion
麻疹病毒 C 蛋白:聚合酶相互作用和先天免疫逃避
  • 批准号:
    9223834
  • 财政年份:
    2017
  • 资助金额:
    $ 2.24万
  • 项目类别:
Development of an anti-paramyxovirus drug targeting accessory C protein
开发针对辅助 C 蛋白的抗副粘病毒药物
  • 批准号:
    16K19140
  • 财政年份:
    2016
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
NIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION OF MHRP GP145 CLADE C PROTEIN
NIAID 临床前开发支持 - MHRP GP145 C 类蛋白的生产
  • 批准号:
    10335108
  • 财政年份:
    2014
  • 资助金额:
    $ 2.24万
  • 项目类别:
NIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION OF MHRP GP145 CLADE C PROTEIN
NIAID 临床前开发支持 - MHRP GP145 C 类蛋白的生产
  • 批准号:
    9915351
  • 财政年份:
    2014
  • 资助金额:
    $ 2.24万
  • 项目类别:
NIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION OF MHRP GP145 CLADE C PROTEIN
NIAID 临床前开发支持 - MHRP GP145 C 类蛋白的生产
  • 批准号:
    8939138
  • 财政年份:
    2014
  • 资助金额:
    $ 2.24万
  • 项目类别:
Structural basis of the inhibition of STAT1 activity by Sendai virus C protein
仙台病毒C蛋白抑制STAT1活性的结构基础
  • 批准号:
    25860341
  • 财政年份:
    2013
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了